This proposal represents the first renewal application of our program project in transplantation immunology. The original focus of this program was on (a) antigen presentation and (b) cytokine regulation of immune cell function: two specific issues of paramount importance to transplant biologists. The current proposal continues this overall focus but now concentrates on the topic of cytokine immunobiology with particular emphasis on TNF and IL-1. Project 2 follows up an observation made by Robert Schreiber, Kathleen Sheehan and Paul Lacy that TNF and IL-1 can profoundly suppress T cell activation and graft rejection responses in normal mice. Schreiber and Sheehan now propose to study the cellular and molecular basis of this immunosuppressive process by examining the effects of these cytokines on antigen presenting cell function and T cell development in vivo and in vitro. Since IL-1 holds such a prominent position in this program project, the third project will characterize the physiologic mechanism by which IL-1beta is activated. Herein, David Chaplin will perform a detailed molecular analysis on a newly defined enzyme that appears to be uniquely required for proteolytically activating murine (and human) IL-1beta. Project 3 will directly apply the principles of cytokine biology which have been and continue to be obtained from our basic research studies to models of xenograft and allograft rejection. Drs. Paul Lacy and David Scharp will expand their studies on the use of TNF, IL-1 and the combination of TGFbeta and anti-IFNgamma to suppress the rejection of pancreatic islet grafts. This project is likely to provide direct benefits to transplantation biologists by better defining the basic mechanisms involved in the induction of immunologic tolerance and by helping to develop novel and safer immunosuppressive therapeutic agents. Thus, the overall benefit of this particular program project continues to be the efficient application of basic immunologic concepts to the field of transplantation biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI024854-06
Application #
3091826
Study Section
Special Emphasis Panel (SRC (25))
Project Start
1992-09-30
Project End
1996-05-31
Budget Start
1992-09-30
Budget End
1993-05-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Nett-Fiordalisi, M; Tomaselli, K; Russell, J H et al. (1995) Macrophage apoptosis in the absence of active interleukin-1 beta-converting enzyme. J Leukoc Biol 58:717-24
Mariathasan, S; Matsumoto, M; Baranyay, F et al. (1995) Absence of lymph nodes in lymphotoxin-alpha(LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J Inflamm 45:72-8
Sheehan, K C; Pinckard, J K; Arthur, C D et al. (1995) Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J Exp Med 181:607-17
Wall, D A; Sheehan, K C (1994) The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency. Transplantation 57:273-9
Goss, J A; Nakafusa, Y; Flye, M W (1993) MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Ann Surg 217:492-9;discussion 499-501
Gerasimidi, A; Sheehan, K C; Schreiber, R D et al. (1993) Tumor necrosis factor-alpha prevents rejection of islet xenografts (rat to mouse). Diabetes 42:651-7
Dighe, A S; Farrar, M A; Schreiber, R D (1993) Inhibition of cellular responsiveness to interferon-gamma (IFN gamma) induced by overexpression of inactive forms of the IFN gamma receptor. J Biol Chem 268:10645-53
Schreiner, G F; Kamei, T; Lefkowith, J et al. (1993) Modulation of the kinetics of the initial leukocyte migration into renal allografts by 16,16-dimethyl PGE2. Transplantation 56:417-22
Nakafusa, Y; Goss, J A; Mohanakumar, T et al. (1993) Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Transplantation 55:877-82
Carel, J C; Sheehan, K C; Schreiber, R D et al. (1993) Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor. Transplantation 55:456-8

Showing the most recent 10 out of 45 publications